Head-To-Head Comparison: Global Cord Blood (NYSE:CO) versus Infrastructure and Energy Alternatives (NYSE:IEA)

Global Cord Blood (NYSE:CO) and Infrastructure and Energy Alternatives (NASDAQ:IEA) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

Valuation & Earnings

This table compares Global Cord Blood and Infrastructure and Energy Alternatives’ gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Global Cord Blood $147.03 million 3.70 $43.38 million N/A N/A
Infrastructure and Energy Alternatives $779.34 million 0.11 $4.24 million ($0.80) -4.61

Global Cord Blood has higher earnings, but lower revenue than Infrastructure and Energy Alternatives.

Volatility and Risk

Global Cord Blood has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Infrastructure and Energy Alternatives has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Global Cord Blood and Infrastructure and Energy Alternatives, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood 0 0 0 0 N/A
Infrastructure and Energy Alternatives 0 1 0 0 2.00

Infrastructure and Energy Alternatives has a consensus target price of $7.00, indicating a potential upside of 89.70%. Given Infrastructure and Energy Alternatives’ higher possible upside, analysts clearly believe Infrastructure and Energy Alternatives is more favorable than Global Cord Blood.

Insider & Institutional Ownership

16.3% of Global Cord Blood shares are held by institutional investors. Comparatively, 13.9% of Infrastructure and Energy Alternatives shares are held by institutional investors. 10.0% of Infrastructure and Energy Alternatives shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Global Cord Blood and Infrastructure and Energy Alternatives’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Global Cord Blood 34.86% 10.88% 5.73%
Infrastructure and Energy Alternatives 0.57% -15.21% 3.32%

Summary

Global Cord Blood beats Infrastructure and Energy Alternatives on 8 of the 11 factors compared between the two stocks.

Global Cord Blood Company Profile

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2018, it had three operating cord blood banks in the Beijing municipality, the Guangdong province, and the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation is a subsidiary of Nanjing Ying Peng Hui Kang Medical Industry Investment Partnership (Limited Partnership).

Infrastructure and Energy Alternatives Company Profile

Infrastructure and Energy Alternatives, Inc., a diversified infrastructure construction company, provides engineering, procurement, and construction services for the renewable energy, traditional power, and civil infrastructure industries in the United States. It offers design, site development, construction, installation, and restoration of infrastructure services. The company was founded in 1947 is headquartered in Indianapolis, Indiana.

Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.